Skip to main content
. Author manuscript; available in PMC: 2011 Nov 11.
Published in final edited form as: Nat Protoc. 2009 Aug 27;4(9):1350–1362. doi: 10.1038/nprot.2009.120

Table 3.

TROUBLESHOOTING

Step Problem Possible Reason Solution
1–16 Wounds noted on dorsal skin Mice are fighting Separate the aggressor, individually house all males and aggressive females; Interpret results with caution since wounding promotes tumor development
13–16 Weight loss Toxicity associated with chemotherapeutic or chemopreventive agent Lower the dose of chemopreventive or chemotherapeutic agent; Interpret results with caution since negative energy balance inhibits tumor response
Lack of food consumption; Dietary delivery of chemotherapeutic or chemopreventive agent has made chow less palatable Change route of delivery; Interpret results with caution since negative energy balance inhibits tumor response
Cachexia due to large tumor burden or malignant progression Sacrifice individual mice and harvest tissue; terminate the experiment if indicated by IACUC regulations. Note: Papilloma counts may be unreliable after the appearance of SCC.
In subsequent experiments reduce the dose of DMBA and/or TPA
12–16 No tumors arise in positive control group Resistant strain was used as a positive control; Dose of initiating or promoting agent too low Use a sensitive strain, backcross transgene or gene deficiency allele to sensitive strain such as FVB. Increase the doses of DMBA/TPA.
Improper composition, storage, or handling of DMBA or TPA solutions Verify solution composition; Prepare a fresh stock of DMBA for each initiation and protect from light; Store TPA solutions at −20°C.
12–16 Predicted effect of therapeutic or preventative agent or genetic manipulation is not detected True negative result Do nothing
False negative results may occur if the doses of DMBA/TPA overwhelm the potential preventative or therapeutic effect of treatment or genetic manipulation Lower the dose of DMBA/TPA
Inadequate statistical power Recalculate the necessary sample size based upon newly collected preliminary data
12–16 Abnormal lesions form Transgene or inhibitor conferred unexpected gross appearance of papillomas Harvest tumors tissues, cut sections and perform histologic investigation.
12–16 Papillomas arise but a portion regresses Tumor regression is normal and the rate at which it occurs depends upon the strain utilized Adjust tumor incidence and multiplicity calculations as necessary